Literature DB >> 31181574

Caffeine and the Dyskinesia Related to Mutations in the ADCY5 Gene.

Aurélie Méneret1, Domitille Gras2, Eavan McGovern1, Emmanuel Roze1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31181574     DOI： 10.7326/L19-0038

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  12 in total

Review 1.  Genetic updates on paroxysmal dyskinesias.

Authors:  James Y Liao; Philippe A Salles; Umar A Shuaib; Hubert H Fernandez
Journal:  J Neural Transm (Vienna)       Date:  2021-04-30       Impact factor: 3.575

2.  ADCY5 Related Dyskinesia-A Rare Mutation.

Authors:  Bandari Mahesh; Varun Kumar Singh; Abhishek Pathak; Anand Kumar; Rameshwar Nath Chaurasia
Journal:  Mov Disord Clin Pract       Date:  2022-02-16

3.  Sleep in ADCY5-Related Dyskinesia: Prolonged Awakenings Caused by Abnormal Movements.

Authors:  Aurélie Méneret; Emmanuel Roze; Jean-Baptiste Maranci; Pauline Dodet; Diane Doummar; Florence Riant; Christine Tranchant; Valérie Fraix; Mathieu Anheim; Asya Ekmen; Eavan McGovern; Marie Vidailhet; Isabelle Arnulf; Smaranda Leu-Semenescu
Journal:  J Clin Sleep Med       Date:  2019-07-15       Impact factor: 4.062

Review 4.  ADCY5-Related Dyskinesia: Improving Clinical Detection of an Evolving Disorder.

Authors:  Nirosen Vijiaratnam; Kailash P Bhatia; Anthony E Lang; Wendy H Raskind; Alberto J Espay
Journal:  Mov Disord Clin Pract       Date:  2019-08-19

Review 5.  Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.

Authors:  Giacomo Garone; Alessandro Capuano; Lorena Travaglini; Federica Graziola; Fabrizia Stregapede; Ginevra Zanni; Federico Vigevano; Enrico Bertini; Francesco Nicita
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

6.  Deep brain stimulation reduces (nocturnal) dyskinetic exacerbations in patients with ADCY5 mutation: a case series.

Authors:  Ana Luísa de Almeida Marcelino; Tina Mainka; Patricia Krause; Werner Poewe; Christos Ganos; Andrea A Kühn
Journal:  J Neurol       Date:  2020-07-09       Impact factor: 4.849

7.  Recurrent ADCY5 Mutation in Mosaic Form with Nocturnal Paroxysmal Dyskinesias and Video Electroencephalography Documentation of Dramatic Response to Caffeine Treatment.

Authors:  Kuldeep Shetty; Asodu Sandeep Sarma; Meera Devan; Ashwin Dalal; Gopal Krishna Dash; Apuroopa Jannabhatla; Siddaramappa Jagadish Patil
Journal:  J Mov Disord       Date:  2020-07-28

Review 8.  Treatable Hyperkinetic Movement Disorders Not to Be Missed.

Authors:  Aurélie Méneret; Béatrice Garcin; Solène Frismand; Annie Lannuzel; Louise-Laure Mariani; Emmanuel Roze
Journal:  Front Neurol       Date:  2021-12-01       Impact factor: 4.003

9.  Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesia.

Authors:  Martina Di Rocco; Serena Galosi; Enrico Lanza; Federica Tosato; Davide Caprini; Viola Folli; Jennifer Friedman; Gianfranco Bocchinfuso; Alberto Martire; Elia Di Schiavi; Vincenzo Leuzzi; Simone Martinelli
Journal:  Hum Mol Genet       Date:  2022-03-21       Impact factor: 6.150

Review 10.  Paroxysmal Movement Disorders.

Authors:  Susan Harvey; Mary D King; Kathleen M Gorman
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.